TFF Pharmaceuticals, Inc.
TFFPDelisted Mar 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001733413
TFF Pharmaceuticals, Inc. was delisted on Mar 6, 2025; its insiders filed their last Form 4 on Jul 8, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $1.48M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding TFF Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 45 | 1 | 41 | −3 |
| Shares | 4.23M | 1.00M | 7.23M | +4.00M (+123.7%) |
| Value | $17.2M | $4.06M | $7.52M | −$5.59M (−42.6%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held TFF Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AIGH Capital Management LLC | 1,739,130 | $1.83M | 0.60% |
| DRW Securities, LLC | 1,000,000 | $1.05M | 0.21% |
| Worth Venture Partners, LLC | 427,824 | $449.2K | 0.27% |
| Millennium Management LLC | 190,047 | $200.0K | 0.00% |
| Renaissance Technologies LLC | 72,155 | $76.0K | 0.00% |
| Two Sigma Investments, LP | 56,954 | $59.8K | 0.00% |
| CI Private Wealth, LLC | 12,000 | $12.6K | 0.00% |
| StoneX Group Inc. | 11,382 | $12.0K | 0.00% |
| Jane Street Group, LLC | 10,761 | $11.3K | 0.00% |
| Thompson Davis & Co., Inc. | 10,000 | $10.5K | 0.01% |
Sold out (13)
Institutions that held TFF Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Raymond James & Associates | 47,450 | $193.0K |
| Mesirow Financial Investment Management, Inc. | 40,013 | $162.0K |
| National Asset Management, Inc. | 27,800 | $113.0K |
| Sanders Morris Harris LLC | 20,826 | $83.0K |
| Qube Research & Technologies Ltd | 19,663 | $80.0K |
| Charles Schwab Investment Management Inc | 11,966 | $49.0K |
| Meridian Wealth Advisors, LLC | 11,500 | $47.0K |
| Venturi Wealth Management, LLC | 8,273 | $34.0K |
| Caption Management, LLC | 5,000 | $21.0K |
| Simplex Trading, LLC | 3,213 | $13.0K |
| Selective Wealth Management, Inc. | 3,200 | $13.0K |
| Royal Bank of Canada | 614 | $2.00K |
| Steward Partners Investment Advisory, LLC | 100 | $0 |
Not filed for Q4 2022 yet (1)
Institutions that held TFF Pharmaceuticals, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| DRW Securities, L.L.C. | 1,000,000 | $4.06M |